IONQ Inc vs Tilray Brands Inc — how do they compare? IONQ Inc trades at $45.12 (market cap $17.60B), while Tilray Brands Inc trades at $4.75 (market cap $649.42M). The key difference: IONQ Inc is far larger — about 27.1× Tilray Brands Inc's market cap, and IONQ Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| IONQ | TLRY | |
|---|---|---|
Market Cap | $17.60B | $649.42M |
Sector | Technology | Health |
52-Week High | $82.09 | $21.00 |
52-Week Low | $26.59 | $3.88 |
Enterprise Value | $15.53B | $816.55M |
Signals from Pluang's Aura AI — not financial advice
IONQ trades at $44.82, up 5.38% with a bullish technical signal supported by moving averages. The quantum computing company reported explosive 287% revenue growth in Q2 2026 to $80.1 million and raised its full-year outlook, though it remains deeply unprofitable with a -553% net margin. Recent catalysts include a $28 million DARPA contract extension and strong analyst sentiment with a $73.33 consensus price target representing 64% upside potential.
While IONQ demonstrates exceptional revenue momentum and technological leadership in quantum computing, investors face substantial risk from persistent losses, high cash burn, and valuation multiples exceeding 60x sales. The stock offers significant growth potential but requires tolerance for volatility and a long-term horizon given the nascent stage of quantum commercialization.
TLRY trades at $4.77, up 7.92% in the last session, with a bullish technical signal from moving averages but mixed oscillators. The company reported record fiscal 2026 revenue of $915 million (GlobeNewsWire, July 28, 2026) but posted a net loss. Key financials show a low P/S of 0.58 and P/B of 0.4, yet profitability remains challenged with negative net income margins and ROE.
Outlook is cautiously optimistic due to revenue growth and diversification into beverages and wellness, but high execution risk persists from consistent losses and competitive pressures. Analyst sentiment is mixed with 25% buy ratings, suggesting potential upside if profitability improves, though near-term volatility is likely.
Trailing returns across standard periods
Latest headlines on both assets
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →